E. Mazzoni

Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

Sabrina Chiara Cecere, Gaia Giannone, Vanda Salutari et al. · Gynecologic Oncology · 2019 · 103 citations · Full text

Medicine, Cancer Management, Gynecology +9

Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer

Palma Fedele, Antonella Marino, Laura Orlando et al. · European Journal of Cancer · 2011 · 98 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +8

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial

Sandro Pignata, Giovanni Scambia, Clorinda Schettino et al. · The Lancet Oncology · 2023 · 46 citations

Medicine, Cancer Management, Mito End-3 +7

BMI Variation Increases Recurrence Risk in Women with Early-Stage Breast Cancer

Palma Fedele, Laura Orlando, Paola Schiavone et al. · Future Oncology · 2014 · 26 citations

Cisplatin plus Gemcitabine as Adjuvant Chemotherapy for Radically Resected Non–Small-Cell Lung Cancer: A Pilot Study

Carmelo Tibaldi, E. Mazzoni, Giandomenico Arcabasso et al. · Clinical Lung Cancer · 2009 · 13 citations

Surgical Oncology, Medicine, Metronomic Therapy +7